Routine ESOP exercise disclosure, no trading signal. Monitor next 20-F or earnings release for fundamental updates on revenue, margins, and regulatory pipeline.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Jun 22 $13.91entry
- T+1 · 5mo ago +2.88%α +4.33% · $14.31
- T+5 · 5mo ago +6.83%α +7.29% · $14.86
- T+20 · 4mo ago −9.42%α −9.27% · $12.60
- T+60 · due 2mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's filed a routine 6-K disclosing a small equity allotment of 6,730 shares upon exercise of employee stock options under existing ESOP schemes. This is a standard administrative disclosure with no new material financial, operational, or regulatory information.
Key Facts
- Allotted 6,730 equity shares of Re.1 each on June 19, 2026 to eligible employees exercising stock options under Dr. Reddy's Employees Stock Option Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
- Exercise prices were Re.1 (2,455 shares), Rs.562.80 (2,000 shares), and Rs.735.80 (2,275 shares) per share.
- Total issued shares post-allotment: 83,46,76,800 equity shares of Re.1 each, representing a negligible 0.008% increase from prior outstanding.
- No lock-in restrictions; shares rank pari passu with existing equity.
Financial Impact
Minimal dilution of approximately 0.008% of outstanding shares; aggregate proceeds from exercises are immaterial relative to the company's $11.7B market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000428 |
| Document: 0001575872-26-000428-index.html | 0001575872-26-000428 |
| Document: 0001575872-26-000428.txt | 0001575872-26-000428 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers